First PRIZM Participant Enrolled in Tisento`s MELAS Study
20 Aug 2025 //
GLOBENEWSWIRE
Tisento Therapeutics Gets FDA Fast Track for Zagociguat for MELAS
17 Jun 2025 //
GLOBENEWSWIRE
Tisento Showcases Mitochondrial Drug Progress at Two Key Events
14 May 2025 //
GLOBENEWSWIRE
Tisento Doses First Patient In Zagociguat Phase 2b PRIZM Study
27 Jan 2025 //
GLOBENEWSWIRE